A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)
In December 2019, a new type viral pneumonia cases occurred in Wuhan, Hubei Province; and then named "2019 novel coronavirus (2019-nCoV)" by the World Health Organization (WHO) on 12 January 2020. For it is a never been experienced respiratory disease before and with infection ability widely and quickly, it attracted the world's attention but without treatment and control manual. For the request from frontline clinicians and public health professionals of 2019-nCoV infected pneumonia management, an evidence-based guideline urgently needs to be developed. Therefore, we drafted this guideline according to the rapid advice guidelines methodology and general rules of WHO guideline development; we also added the first-hand management data of Zhongnan Hospital of Wuhan University. This guideline includes the guideline methodology, epidemiological characteristics, disease screening and population prevention, diagnosis, treatment and control (including traditional Chinese Medicine), nosocomial infection prevention and control, and disease nursing of the 2019-nCoV. Moreover, we also provide a whole process of a successful treatment case of the severe 2019-nCoV infected pneumonia and experience and lessons of hospital rescue for 2019-nCoV infections. This rapid advice guideline is suitable for the first frontline doctors and nurses, managers of hospitals and healthcare sections, community residents, public health persons, relevant researchers, and all person who are interested in the 2019-nCoV.
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
|---|---|
| Enthalten in: |
Military Medical Research - 7(2020), 1 vom: 06. Feb., Seite 4 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 19.03.2020 Date Revised 03.11.2023 published: Electronic CommentIn: Mil Med Res. 2020 Apr 4;7(1):16. - PMID 32245395 Citation Status MEDLINE |
|---|
| doi: |
10.1186/s40779-020-0233-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM306236613 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM306236613 | ||
| 003 | DE-627 | ||
| 005 | 20231225122923.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s40779-020-0233-6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1020.xml |
| 035 | |a (DE-627)NLM306236613 | ||
| 035 | |a (NLM)32029004 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Jin, Ying-Hui |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.03.2020 | ||
| 500 | |a Date Revised 03.11.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a CommentIn: Mil Med Res. 2020 Apr 4;7(1):16. - PMID 32245395 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a In December 2019, a new type viral pneumonia cases occurred in Wuhan, Hubei Province; and then named "2019 novel coronavirus (2019-nCoV)" by the World Health Organization (WHO) on 12 January 2020. For it is a never been experienced respiratory disease before and with infection ability widely and quickly, it attracted the world's attention but without treatment and control manual. For the request from frontline clinicians and public health professionals of 2019-nCoV infected pneumonia management, an evidence-based guideline urgently needs to be developed. Therefore, we drafted this guideline according to the rapid advice guidelines methodology and general rules of WHO guideline development; we also added the first-hand management data of Zhongnan Hospital of Wuhan University. This guideline includes the guideline methodology, epidemiological characteristics, disease screening and population prevention, diagnosis, treatment and control (including traditional Chinese Medicine), nosocomial infection prevention and control, and disease nursing of the 2019-nCoV. Moreover, we also provide a whole process of a successful treatment case of the severe 2019-nCoV infected pneumonia and experience and lessons of hospital rescue for 2019-nCoV infections. This rapid advice guideline is suitable for the first frontline doctors and nurses, managers of hospitals and healthcare sections, community residents, public health persons, relevant researchers, and all person who are interested in the 2019-nCoV | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Practice Guideline | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a 2019 novel coronavirus | |
| 650 | 4 | |a 2019-nCoV | |
| 650 | 4 | |a Clinical practice guideline | |
| 650 | 4 | |a Evidence-based medicine | |
| 650 | 4 | |a Infectious diseases | |
| 650 | 4 | |a Pneumonia | |
| 650 | 4 | |a Rapid advice guideline | |
| 650 | 4 | |a Respiratory disease | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 650 | 7 | |a Drugs, Chinese Herbal |2 NLM | |
| 700 | 1 | |a Cai, Lin |e verfasserin |4 aut | |
| 700 | 1 | |a Cheng, Zhen-Shun |e verfasserin |4 aut | |
| 700 | 1 | |a Cheng, Hong |e verfasserin |4 aut | |
| 700 | 1 | |a Deng, Tong |e verfasserin |4 aut | |
| 700 | 1 | |a Fan, Yi-Pin |e verfasserin |4 aut | |
| 700 | 1 | |a Fang, Cheng |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Di |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Lu-Qi |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Qiao |e verfasserin |4 aut | |
| 700 | 1 | |a Han, Yong |e verfasserin |4 aut | |
| 700 | 1 | |a Hu, Bo |e verfasserin |4 aut | |
| 700 | 1 | |a Hu, Fen |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Bing-Hui |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Yi-Rong |e verfasserin |4 aut | |
| 700 | 1 | |a Liang, Ke |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Li-Kai |e verfasserin |4 aut | |
| 700 | 1 | |a Luo, Li-Sha |e verfasserin |4 aut | |
| 700 | 1 | |a Ma, Jing |e verfasserin |4 aut | |
| 700 | 1 | |a Ma, Lin-Lu |e verfasserin |4 aut | |
| 700 | 1 | |a Peng, Zhi-Yong |e verfasserin |4 aut | |
| 700 | 1 | |a Pan, Yun-Bao |e verfasserin |4 aut | |
| 700 | 1 | |a Pan, Zhen-Yu |e verfasserin |4 aut | |
| 700 | 1 | |a Ren, Xue-Qun |e verfasserin |4 aut | |
| 700 | 1 | |a Sun, Hui-Min |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Ying |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Yun-Yun |e verfasserin |4 aut | |
| 700 | 1 | |a Weng, Hong |e verfasserin |4 aut | |
| 700 | 1 | |a Wei, Chao-Jie |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Dong-Fang |e verfasserin |4 aut | |
| 700 | 1 | |a Xia, Jian |e verfasserin |4 aut | |
| 700 | 1 | |a Xiong, Yong |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Hai-Bo |e verfasserin |4 aut | |
| 700 | 1 | |a Yao, Xiao-Mei |e verfasserin |4 aut | |
| 700 | 1 | |a Yuan, Yu-Feng |e verfasserin |4 aut | |
| 700 | 1 | |a Ye, Tai-Sheng |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Xiao-Chun |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Ying-Wen |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Yin-Gao |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Hua-Min |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, Yan |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, Ming-Juan |e verfasserin |4 aut | |
| 700 | 1 | |a Zi, Hao |e verfasserin |4 aut | |
| 700 | 1 | |a Zeng, Xian-Tao |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Yong-Yan |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Xing-Huan |e verfasserin |4 aut | |
| 700 | 0 | |a , for the Zhongnan Hospital of Wuhan University Novel Coronavirus Management and Research Team, Evidence-Based Medicine Chapter of China International Exchange and Promotive Association for Medical and Health Care (CPAM) |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Military Medical Research |d 2014 |g 7(2020), 1 vom: 06. Feb., Seite 4 |w (DE-627)NLM246615990 |x 2054-9369 |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2020 |g number:1 |g day:06 |g month:02 |g pages:4 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s40779-020-0233-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 7 |j 2020 |e 1 |b 06 |c 02 |h 4 | ||